Fulgent Genetics
FLGT
256 hedge funds and large institutions have $973M invested in Fulgent Genetics in 2021 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 28 closing their positions.
214% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 28
91% more capital invested
Capital invested by funds: $509M → $973M (+$464M)
34% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 64
31% more funds holding
Funds holding: 196 → 256 (+60)
5.27% less ownership
Funds ownership: 40.14% → 34.87% (-5.3%)
20% less call options, than puts
Call options by funds: $104M | Put options by funds: $131M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$62.1M |
| 2 |
Morgan Stanley
New York
|
+$30.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$25.4M |
| 2 |
RJT
Raymond James Trust
St. Petersburg,
Florida
|
-$17.6M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$17.2M |
| 4 |
OWIM
Old West Investment Management
Los Angeles,
California
|
-$12.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$11.5M |
FLGT Hedge Fund Activity: Q1 2021 in Review
256 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2021, worth a combined $973M — up 91% from $509M a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new FLGT positions and 28 closed out — a net gain of 60 holders — while 86 added to existing stakes and 64 trimmed.
The largest buyer was BlackRock, adding an estimated $62.1M. The largest seller was Russell Investments Group, cutting an estimated $25.4M.
- 256 institutional investors held Fulgent Genetics (FLGT) as of Q1 2021, up from 196 in Q4 2020.
- Funds reported $973M of Fulgent Genetics stock for Q1 2021, up 91% quarter-over-quarter.
- 88 funds opened new Fulgent Genetics positions in Q1 2021 and 28 closed out, a net change of +60 holders.
- The largest Fulgent Genetics buyer in Q1 2021 was BlackRock, an estimated $62.1M added.
- The largest Fulgent Genetics seller in Q1 2021 was Russell Investments Group, an estimated $25.4M sold.
Based on aggregated 13F filings for Q1 2021.